Literature DB >> 3229426

Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe.

D Hackett1, G Davies, A Maseri.   

Abstract

The sudden, often unheralded, onset of symptoms in acute myocardial infarction suggests that pre-existing coronary stenoses susceptible to acute thrombosis in the infarct-related artery may not necessarily have been severe. We investigated the severity of residual coronary stenoses after successful thrombolytic recanalization and the relationship to previous symptoms, collateral vessels and the extent of coronary artery disease in 60 consecutive patients at the time of presentation of their first acute myocardial infarction by performing quantitative coronary arteriography before, during and after intracoronary thrombolytic therapy. Recanalization was achieved in 48 (80%) patients with a residual stenosis of 58.1 +/- 10.8% (mean +/- ISD; range 33-82%) obstruction diameter and a minimum lumen calibre of 1.10 +/- 0.3 mm (range 0.39-1.95 mm). A residual stenosis of less than 60% obstruction diameter was present in 28 (47%) patients. When residual stenoses were mild, no acute collateral filling of the occluded artery was observed. After thrombolysis, residual infarct-related coronary stenoses in patients with their first acute myocardial infarction are not necessarily severely obstructive. This raises the problem of identifying which non-obstructive coronary stenoses are likely to occlude suddenly and why they do so.

Entities:  

Mesh:

Year:  1988        PMID: 3229426     DOI: 10.1093/oxfordjournals.eurheartj.a062449

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  44 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 2.  Arterial thrombosis--insidious, unpredictable and deadly.

Authors:  Shaun P Jackson
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

3.  Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease.

Authors:  Gjin Ndrepepa; Tomohisa Tada; Massimiliano Fusaro; Salvatore Cassese; Lamin King; Martin Hadamitzky; Hans-Ullrich Haase; Albert Schömig; Adnan Kastrati; Jürgen Pache
Journal:  Clin Res Cardiol       Date:  2012-07-08       Impact factor: 5.460

Review 4.  Imaging of atherosclerotic plaque using radiofrequency ultrasound signal processing.

Authors:  Stéphane G Carlier; Gary S Mintz; Gregg W Stone
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 5.  Imaging of atherosclerosis.

Authors:  D R J Owen; A C Lindsay; R P Choudhury; Z A Fayad
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

6.  High resolution magnetic resonance imaging of atherosclerosis and the response to balloon angioplasty.

Authors:  R A Coulden; H Moss; M J Graves; D J Lomas; D S Appleton; P L Weissberg
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

7.  Early remodelling of coronary stenoses after thrombolytic treatment in patients with acute myocardial infarction.

Authors:  D Tousoulis; F Andreotti; D Hackett; A W Haider; A Maseri; G Davies
Journal:  Br Heart J       Date:  1995-09

8.  Correlation of antecedent stress myocardial perfusion imaging with the infarct related artery in ST-elevation myocardial infarction.

Authors:  Yumiko Kanei; Yili Huang; John T Fox; Maurice Rachko; Steven R Bergmann
Journal:  Int J Cardiovasc Imaging       Date:  2008-09-12       Impact factor: 2.357

Review 9.  Atherosclerosis--reversal with therapy.

Authors:  D H Blankenhorn; H N Hodis
Journal:  West J Med       Date:  1993-08

10.  Genistein supplementation inhibits atherosclerosis with stabilization of the lesions in hypercholesterolemic rabbits.

Authors:  Choong-Sik Lee; Su-Jin Kwon; Sun-Young Na; Seung-Pyung Lim; Jung-Hee Lee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.